Cicor Technologies Ltd.

Latest Results (09.11.2025):

Cicor Technologies Ltd.'s nine‐month results for 2024 (covering Q1–Q3 2024) show strong overall performance with significant growth in net sales, EBITDA, and net profit compared to the previous year, alongside successful integration of new acquisitions. The report highlights robust divisional contributions, improved cash flows, and a strengthened balance sheet, positioning the company well for the full-year outlook despite current market challenges.

Robust Sales and Profit Growth

Net sales increased by 19.4% from CHF 294.5 million in the prior period to CHF 351.7 million, while EBITDA rose sharply from CHF 32.9 million to CHF 40.7 million. Net profit surged by 52%, climbing from CHF 11.5 million to CHF 17.4 million, with earnings per share moving from CHF 2.59 to CHF 3.95.

Strong Divisional Performance

The EMS Division achieved sales of CHF 318.9 million—a 21% increase—and its EBITDA grew by 24% to CHF 39.7 million. The AS Division also delivered solid results with an 8.3% organic sales increase to CHF 34.6 million and a 25% rise in EBITDA, reaching CHF 5.1 million.

Positive Cash Flow and Balance Sheet Improvements

The free cash flow before acquisitions notably increased to CHF 37.4 million from CHF 10.8 million, driven by reduced net current assets and successful contributions from new acquisitions. Additionally, the balance sheet was strengthened with an improved equity ratio and a reduced net debt-to-EBITDA leverage.

Outlook for Full Year 2024

Despite challenges from the strong Swiss Franc impacting sales, Cicor Technologies Ltd. expects resilience in its operating business. The company projects full-year sales in the range of CHF 470–490 million and EBITDA between CHF 55–60 million, supported by ongoing margin improvements and its strategic growth plans.